Skip to main navigation Skip to search Skip to main content

A Randomized, Partial-Blinded, Multi-Center, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Human Plasma-Derived, Alpha-Proteinase Inhibitor, in Children and Adults with Recent-Onset Type 1 Diabetes Mellitus

Project: Research

Project Details

StatusFinished
Effective start/end date05/12/14 → 10/31/18

Funding

  • Grifols Incorporated: $10,238.00